Government figures show Medicaid spending on these drugs jumping from roughly $600 million in 2019 to nearly $4 billion within a few years, even as the number of states covering them for obesity has fallen
Predictive significance of changes in dietary restraint in obese patients with binge eating disorder during treatment
Since GHRP-2 mimics ghrelin, it helps modulate appetite, metabolism, and energy usage
Another study compared the effects of different antidiabetic treatments, including GLP-1RA, SGLT-2 inhibitors, and their combination, versus insulin
The gut microbiota: A puppet master in the pathogenesis of endometriosis
As a board-certified physician in obesity medicine and obstetrics/gynecology, I see firsthand how womens bodies undergo profound metabolic shifts